Pfizer’s TRUMENBA® to Help Prevent Meningococcal Group B Disease in Adolescents and Adults is now available in Malta
Meningococcal Group B (MenB) is Responsible for 60 Percent of Meningococcal Disease Cases in Adolescents and Young Adults in Europe[1]
New Glaucoma Procedure Performed in Malta
On the 15th June, a new glaucoma procedure was performed for the first time in Malta, as part of a surgeon training session organised by Allergan. The new XEN implant forms part of Allergan’s Eyecare portfolio distributed by Vivian Corporation.
World Preeclampsia Day – May 22, 2017
NICE recommends Roche Diagnostic’s blood test to help rule-out pre-eclampsia in women between their 20th and 35th week of pregnancy. This blood test is more specifically known as the Elecsys immunoassay sFIt-1/PIGF ratio (Roche Diagnostics).
Call for applications – Full Time Regulatory Affairs and Quality Assurance Officer/Responsible Person
Vivian Corporation is an established leader in the marketing of diverse brands which are driven with one unifying goal, to improve the quality of life by creating better opportunities for our customers, patients and consumers alike.
New Study Shows Omega-3 Supplementation Reduces Biological Age
A new pilot study has found that omega-3 long chain polyunsaturated fatty acid (LC-PUFA) supplementation can reduce shortening of telomeres, a phenomenon that occurs as cells age and is related to degeneration and death1.
Chronic constipation
Constipation can be a persistent condition with multiple, bothersome symptoms, which can impact negatively on a patient’s quality of life.1
Nimenrix vaccine being distributed by Vivian Corporation
Vivian Corporation, together with Pfizer, believe in the promise and value of vaccine in improving people’s life. Following Pfizer’s acquisition of Nimenrix from GSK, Vivian Corporation is now the sole distributor responsible for this important addition to the meningitis vaccine portfolio.
World Meningitis Day – 24 April 2016
The Word Meningitis Day Campaign was organised by Vivian Corporation and supported by Amputees4Amputees, the Malta Pharmaceutical Students Association (MPSA) and the Local Councils of Valletta and Sliema.
Burden of Chronic Constipation
Constipation is a common and generally mild and short-term complaint for most individuals. However, for a proportion of patients, constipation can be a chronic and sometimes bothersome condition that represents a substantial burden in terms of its effects on quality of life (QoL).1